FDA rules out Fosamax, thigh fracture link

March 11, 2010 – 6:25 pm

March 10: Two small studies suggest that a small percentage of patients who use certain drugs to prevent bone loss for more than five years could be at greater risk for a rare type of hip fracture. NBC's Robert Bazell reports.  (Nightly News)U.S. regulators said they have found no link between oral bisphosphonate osteoporosis medications such as Merck & Co Inc.’s Fosamax and certain thigh bone fractures.





Related Info :

Tags: , , , , , , , , , , , , ,

Post a Comment